This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Santoni-Rugiu, E. Articles by Thorgeirsson, S. S. Search for Related Content PubMed PubMed Citation Articles by Santoni-Rugiu, E. Articles by Thorgeirsson, S. S.

Disruption of the pRb/E2F Pathway and Inhibition of Apoptosis Are Major Oncogenic Events in Liver Constitutively Expressing c-myc and Transforming Growth Factor ¹

Laboratory of Experimental Carcinogenesis, Division of Basic Sciences, National Cancer Institute, Bethesda, Maryland 20892-4255

The oncogene c-myc and transforming growth factor (TGF) are frequently coexpressed in human cancers, suggesting that their interaction may be a critical step in malignant growth. Consistent with this idea, we recently demonstrated in a transgenic mouse model that TGF- dramatically enhances c-myc-induced hepatocarcinogenesis. To elucidate this synergistic effect, we have now investigated regulation of cell cycle and apoptosis during neoplastic development in the liver of c-myc and c-myc/TGF transgenic mice. Both lines displayed dramatic increases of mitotic and apoptotic rates before the onset of hepatocellular carcinoma (HCC), but only c-myc/TGF- livers showed significantly levels of net proliferation (mitosis minus apoptosis). Subsequently, mitosis declined in peritumorous tissues, concomitant with the previously reported induction of TGF-ß1, whereas c-myc and c-myc/TGF HCCs maintained mitotic hyperactivity. The c-myc/TGF- HCCs were also characterized by a particularly strong expression of TGF- and very low apoptotic index in contrast to high levels of apoptosis in peritumorous tissues and c-myc HCCs. The differential levels of cell proliferation in noncancerous and cancerous tissues correlated with a stronger induction of cyclin D1 mRNA and protein in c-myc/TGF- and c-myc HCCs associated with intense pRb hyperphosphorylation. Severe deregulation of G₁-S transition was also indicated by the dramatic up-regulation, particularly in the HCCs, of pRb-free E2F1-DP1 and E2F2-DP1 transcription factor heterodimers, as assessed by immunoprecipitation and immunohistochemistry. The existence of increased E2F activity during hepatocarcinogenesis was further indicated by the transcriptional induction of putative E2F target genes involved in cell cycle progression, such as endogenous c-myc, cyclin A, Cdc2, and E2F itself. Cdc2 overexpression and the elevated mitotic indices in the HCCs correlated also with induction of cyclin B steady-state levels. The data suggest that coexpression of c-myc and TGF- leads to a selective growth advantage for hepatic (pre)neoplastic cells by disrupting the pRb/E2F pathway and by TGF--mediated reduction of apoptosis.

¹ Supported in part by the Danish Cancer Society (to M. R. J.).

² To whom requests for reprints should be addressed, at National Cancer Institute, Building 37, Room 3C28, 37 Convent Drive, MSC4255, Bethesda, MD 20892-4255. Phone: (301) 496-5688; Fax: (301) 496-0734; E-mail: snorri_thorgeirsson@nih.gov.

Received 8/18/97. Accepted 10/29/97.

This article has been cited by other articles:

				D. F. Calvisi, F. Pinna, F. Meloni, S. Ladu, R. Pellegrino, M. Sini, L. Daino, M. M. Simile, M. R. De Miglio, P. Virdis, et al. Dual-Specificity Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase-Mediated Control of Growth in Human Hepatocellular Carcinoma Cancer Res., June 1, 2008; 68(11): 4192 - 4200. [Abstract] [Full Text] [PDF]

				R. S.Y. Cheung, J. T. Brooling, M. M. Johnson, K. J. Riehle, J. S. Campbell, and N. Fausto Interactions between MYC and transforming growth factor alpha alter the growth and tumorigenicity of liver progenitor cells Carcinogenesis, December 1, 2007; 28(12): 2624 - 2631. [Abstract] [Full Text] [PDF]

				X.-M. Ou, K. Chen, and J. C. Shih Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway PNAS, July 18, 2006; 103(29): 10923 - 10928. [Abstract] [Full Text] [PDF]

				L. G. Cavin, F. Wang, V. M. Factor, S. Kaur, M. Venkatraman, S. S. Thorgeirsson, and M. Arsura Transforming Growth Factor-{alpha} Inhibits the Intrinsic Pathway of c-Myc-Induced Apoptosis through Activation of Nuclear Factor-{kappa}B in Murine Hepatocellular Carcinomas Mol. Cancer Res., July 1, 2005; 3(7): 403 - 412. [Abstract] [Full Text] [PDF]

				D. F. Calvisi and S. S. Thorgeirsson Molecular Mechanisms of Hepatocarcinogenesis in Transgenic Mouse Models of Liver Cancer Toxicol Pathol, January 1, 2005; 33(1): 181 - 184. [Abstract] [Full Text] [PDF]

				L. G. Cavin, M. Venkatraman, V. M. Factor, S. Kaur, I. Schroeder, F. Mercurio, A. A. Beg, S. S. Thorgeirsson, and M. Arsura Regulation of {alpha}-Fetoprotein by Nuclear Factor-{kappa}B Protects Hepatocytes from Tumor Necrosis Factor-{alpha} Cytotoxicity during Fetal Liver Development and Hepatic Oncogenesis Cancer Res., October 1, 2004; 64(19): 7030 - 7038. [Abstract] [Full Text] [PDF]

				H. Huynh Overexpression of tumour suppressor retinoblastoma 2 protein (pRb2/p130) in hepatocellular carcinoma Carcinogenesis, August 1, 2004; 25(8): 1485 - 1494. [Abstract] [Full Text] [PDF]

				D. F. Calvisi, S. Ladu, V. M. Factor, and S. S. Thorgeirsson Activation of {beta}-catenin provides proliferative and invasive advantages in c-myc/TGF-{alpha} hepatocarcinogenesis promoted by phenobarbital Carcinogenesis, June 1, 2004; 25(6): 901 - 908. [Abstract] [Full Text] [PDF]

				M. M. Simile, M. R. De Miglio, M. R. Muroni, M. Frau, G. Asara, S. Serra, M. D. Muntoni, M. A. Seddaiu, L. Daino, F. Feo, et al. Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells Carcinogenesis, March 1, 2004; 25(3): 333 - 341. [Abstract] [Full Text] [PDF]

				M. Nakau, H. Miyoshi, M. F. Seldin, M. Imamura, M. Oshima, and M. M. Taketo Hepatocellular Carcinoma Caused by Loss of Heterozygosity in Lkb1 Gene Knockout Mice Cancer Res., August 15, 2002; 62(16): 4549 - 4553. [Abstract] [Full Text] [PDF]

				M. R. De Miglio, R. M. Pascale, M. M. Simile, M. R. Muroni, D. F. Calvisi, P. Virdis, G. M. Bosinco, M. Frau, M. A. Seddaiu, S. Ladu, et al. Chromosome Mapping of Multiple Loci Affecting the Genetic Predisposition to Rat Liver Carcinogenesis Cancer Res., August 1, 2002; 62(15): 4459 - 4463. [Abstract] [Full Text] [PDF]

				D. F. Calvisi, V. M. Factor, R. Loi, and S. S. Thorgeirsson Activation of {beta}-Catenin during Hepatocarcinogenesis in Transgenic Mouse Models: Relationship to Phenotype and Tumor Grade Cancer Res., March 1, 2001; 61(5): 2085 - 2091. [Abstract] [Full Text]

				B. M. Alderman, G. A. Cook, M. Familari, N. D. Yeomans, and A. S. Giraud Resistance to apoptosis is a mechanism of adaptation of rat stomach to aspirin Am J Physiol Gastrointest Liver Physiol, June 1, 2000; 278(6): G839 - G846. [Abstract] [Full Text] [PDF]

				E. Santoni-Rugiu, J. Falck, N. Mailand, J. Bartek, and J. Lukas Involvement of Myc Activity in a G1/S-Promoting Mechanism Parallel to the pRb/E2F Pathway Mol. Cell. Biol., May 15, 2000; 20(10): 3497 - 3509. [Abstract] [Full Text]

				S.-L. Y. Feng, Y. Guo, V. M. Factor, S. S. Thorgeirsson, D. W. Bell, J. R. Testa, K. A. Peifley, and J. A. Winkles The Fn14 Immediate-Early Response Gene Is Induced During Liver Regeneration and Highly Expressed in Both Human and Murine Hepatocellular Carcinomas Am. J. Pathol., April 1, 2000; 156(4): 1253 - 1261. [Abstract] [Full Text] [PDF]

				E. Santoni-Rugiu, M. R. Jensen, V. M. Factor, and S. S. Thorgeirsson Acceleration of c-myc-Induced Hepatocarcinogenesis by Co-Expression of Transforming Growth Factor (TGF)-{alpha} in Transgenic Mice Is Associated with TGF-ß1 Signaling Disruption Am. J. Pathol., June 1, 1999; 154(6): 1693 - 1700. [Abstract] [Full Text] [PDF]

				E. R. Lemmer, P. de la Motte Hall, N. Omori, M. Omori, E. G. Shephard, W. C.A. Gelderblom, J. P. Cruse, R. A. Barnard, W. F.O. Marasas, R. E. Kirsch, et al. Histopathology and gene expression changes in rat liver during feeding of fumonisin B1, a carcinogenic mycotoxin produced by Fusarium moniliforme Carcinogenesis, May 1, 1999; 20(5): 817 - 824. [Abstract] [Full Text] [PDF]

				L. M. Sargent, X. Zhou, C. L. Keck, N. D. Sanderson, D. B. Zimonjic, N. C. Popescu, and S. S. Thorgeirsson Nonrandom Cytogenetic Alterations in Hepatocellular Carcinoma from Transgenic Mice Overexpressing c-Myc and Transforming Growth Factor-{alpha} in the Liver Am. J. Pathol., April 1, 1999; 154(4): 1047 - 1055. [Abstract] [Full Text] [PDF]

				H. A.J. Schut and E. G. Snyderwine DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis Carcinogenesis, March 1, 1999; 20(3): 353 - 368. [Abstract] [Full Text] [PDF]

				S. Sanders and S. S. Thorgeirsson Phenobarbital promotes liver growth in c-myc/TGF-{alpha} transgenic mice by inducing hypertrophy and inhibiting apoptosis Carcinogenesis, January 1, 1999; 20(1): 41 - 49. [Abstract] [Full Text] [PDF]

				N. Wong, P. Lai, S.-W. Lee, S. Fan, E. Pang, C.-T. Liew, Z. Sheng, J. W.-Y. Lau, and P. J. Johnson Assessment of Genetic Changes in Hepatocellular Carcinoma by Comparative Genomic Hybridization Analysis : Relationship to Disease Stage, Tumor Size, and Cirrhosis Am. J. Pathol., January 1, 1999; 154(1): 37 - 43. [Abstract] [Full Text] [PDF]

				V. M. Factor, A. Kiss, J. T. Woitach, P. J. Wirth, and S. S. Thorgeirsson Disruption of Redox Homeostasis in the Transforming Growth Factor-alpha /c-myc Transgenic Mouse Model of Accelerated Hepatocarcinogenesis J. Biol. Chem., June 19, 1998; 273(25): 15846 - 15853. [Abstract] [Full Text] [PDF]